Cita APA (7th ed.)

Sallman, D., Al Malki, M., Asch, A., Wang, E., Jurcic, J., Bradley, T., . . . Daver, N. (2023). Magrolimab in combination with azacitidine in patients with higher-risk myelodysplastic syndromes: Final results of a phase Ib study. American Society of Clinical Oncology.

Cita Chicago (17th ed.)

Sallman, DA, et al. Magrolimab in Combination with Azacitidine in Patients with Higher-risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study. American Society of Clinical Oncology, 2023.

Cita MLA (9th ed.)

Sallman, DA, et al. Magrolimab in Combination with Azacitidine in Patients with Higher-risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study. American Society of Clinical Oncology, 2023.